By Tom Winnifrith, the Sheriff of AIM | Friday 18 February 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Shield Therapeutics (STX) has the status Omega Diagnostics (ODX) once had as a darling of the Bulletin Board savants. And like Omega was this company is heading for a cash crisis and its shares will tank by 80%. Though this will enrage a shareholder base with the collective IQ of a cheese sandwich, the shares are a stand out short at 25.5p with a 5.5p target. Chaps and gals ,before you start the hate attacks on me learn from the Omega debacle HERE. Now as to why Shield shares will collapse, here’s why.
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Time left: 10:13:51